Search
Filter Results
Displaying 321–330 of 693 for “retinal diseases”
-
My Retina Tracker Genetic Testing Program
The Foundation Fighting Blindness, in partnership with PreventionGenetics and InformedDNA®, offers an open access, no-cost genetic testing program called the My Retina Tracker® Genetic Testing Program.
-
Jul 9, 2019
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
Research NewsA clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
-
Sep 5, 2018
Vision Improvements Reported in ProQR's Clinical Trial for LCA10 Treatment
Research NewsThe company reported that 60 percent of subjects in the trial demonstrated improvements in visual acuity and their ability to navigate a mobility course. The treatment was also safe for patients.
-
Sep 26, 2013
New Imaging Technique May Be Game-Changer for RP Clinical Trials
Research NewsKnown as EZ Width, it holds potential for reducing the time, cost and number of patients needed to determine if a therapy is working in a clinical trial.
-
Jan 8, 2026
RD Fund Invests in Beacon Therapeutics to Advance XLRP Gene Therapy
Research NewsThe venture philanthropy arm of the Foundation partnered with other investors to support the development of a gene therapy trial for X-linked retinitis pigmentosa (XLRP).
-
Vision Science Explained Through Animated Videos
This educational series aims to educate and inform viewers by simplifying science – helping people understand topics like blinding diseases, genetics, and clinical trials, without requiring advanced background knowledge.
-
May 12, 2025
Research NewsPart B of the trial will enroll nine adult patients as well as three pediatric patients.
-
Dec 13, 2024
Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy
Research NewsKnown as ultevursen, the USH2A RNA therapy was licensed from ProQR.
-
Sep 18, 2024
AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical Trial
Research NewsThe trial is the first ever for a dual AAV gene therapy delivered to the retina.
-
Join the Foundation Fighting Blindness for our new program, Vision Connection, an enriching and supportive gathering for the blind and low vision community.